Dr M Wayengera wins 1st Prize for the WHO Innovation Challenge (Product Development Category) - Congratulations!
On Monday 19 August 2019, the World Health Organisation (AFRO) awarded Dr Misaki Wayengera the 1st prize for the WHO Innovation Challenge in the Product Development Category.
Dr Wayengera (TMA2016CDF1545) and his team from Makerere University have developed a rapid test for Ebola that has the potential to be used for cross boarder screening.
Congratulations on this great achivement!
https://www.basepairbio.com/elasa-aptamer-based-elisa/
New publication by Prof. Jean Nachega - Achieving Viral Suppression in 90% of People Living with HIV on ART in LMICs: Progress, Challenges, and Opportunities
Although significant progress has been made, the latest data from low- and middle-income countries show substantial gaps in reaching the third “90%” (viral suppression) of the UNAIDS 90-90-90 goals, especially among vulnerable and key populations. This article discusses critical gaps and promising, evidence-based solutions. There is no simple and/or single approach to achieve the last 90%. This will require multifaceted, scalable strategies that engage people living with human immunodeficiency virus, motivate long-term treatment adherence, and are community-entrenched and ‑supported, cost-effective, and tailored to a wide range of global communities.
Abstracts Open WSPID 2022: Advancing science together - 22-24 February 2022 (virtual)
Abstract submission for the 12th World Congress of the World Society for Pediatric Infectious Diseases is now open! We invite you to contribute to the outstanding scientific program by submitting your latest research in the field, in any of these topics.
Your work will gain unrivaled exposure amongst international medical and scientific professionals. We are excited to learn from your research and knowledge and impact the future of pediatric infectious diseases together.
Abstract submission deadline is 8 September 2021.
For more information visit https://wspid2022.com/abstract-submission/
Virtual Meeting: HIV Prevention Review Meeting 2021, 2 June 2021
The HIV Prevention Program is happening on June 2 from 9:00 AM - 12:00 PM PDT. This program will start with a state-of-the-art update on HIV vaccines by Dr. Larry Corey, followed by an in-depth look at a variety of PrEP strategies, including daily oral and 2-1-1 PrEP, long-acting injectable cabotegravir, and newer agents entering the testing pipeline. You’ll hear from some of the world’s leading researchers on HIV PrEP, and we’ll close with a roundtable discussion, in which we’ll take questions from the audience to discuss the future of HIV prevention. Don’t miss this opportunity to learn about the current state of PrEP and what the future holds for HIV prevention.
Registration fees are waived for healthcare professionals. We welcome everyone involved in HIV prevention to join this important program.
Program Overview
• 09:00 AM PDT: Plenary Talk: HIV Vaccine Landscape
• 09:25 AM PDT: Session 1: Oral PrEP Today – Where Do We Stand?
• 10.00 AM PDT: Session 2: Long-Acting Injectable PrEP
• 11.20 AM PDT: Roundtable Discussion: Where is HIV Prevention Going?
To register visit https://virology.eventsair.com/hivpre2021/registration/Site/Register